Commentary

[摘要] The foregoing article and comments create a dilemma for pediatricians. The experimental evidence cited is quite convincing that increased amounts of serum albumin decrease the neurotoxic effects of bilirubin. If physicians are convinced of its usefulness, they will want to use this additional treatment for hyperbilirubinemia when it is indicated. Unfortunately, well established therapeutic guidelines do not exist. Serum albumin does not need to be administered to all infants requiring exchange transfusions. Some tentative answers to the questions of which infants should be treated and the amount of serum albumin to be used have been suggested by Dr. Odell in his comments.

[学科分类] 儿科学